Condition: Cushing Syndrome · Sponsor: RECORDATI GROUP
Multicenter, open-label, non-comparative study to evaluate the pharmacokinetics, pharmacodynamics, and tolerability of osilodrostat in children and adolescent patients with Cushing's syndrome.
This description comes directly from the study's public registry record.
Recordati · +39 0248787456 · casi.m@recordati.it
Recordati · +4161 205 61 00
Always discuss trial participation with your own doctor first.
| University of California San Francisco UCSF | San Francisco, California, United States | Recruiting |
| ABMED Clinical Research Corp | Cape Coral, Florida, United States | Recruiting |
| Ann & Robert H. Lurie Children's Hospital | Chicago, Illinois, United States | Recruiting |
| National Institute of Child Health and Human Development | Bethesda, Maryland, United States | Completed |
| Texas Valley Clinical Research | Weslaco, Texas, United States | Recruiting |
| UZ Brussel | Jette, Brussels Capital, Belgium | Completed |
| Multiprofile Hospital for Active Treatment Sveta Marina EAD | Varna, Bulgaria | Withdrawn |
| Hospital Necker Enfants Malades | Paris, France | Completed |
| Robert Debre Hospital | Paris, France | Completed |
| CHU Bicetre APHP Paris Saclay | Paris, France | Completed |
| Aziendal Ospedaliero Universitaria Pisana Presidio Ospedale di Cisanello | Pisa, PI, Italy | Completed |
| Ospedale Bambino Gesu | Roma, Italy | Completed |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03708900